相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。In vitro and in vivo glucuronidation of midazolam in humans
Ruth Hyland et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Methodological Uncertainty in Quantitative Prediction of Human Hepatic Clearance from In Vitro Experimental Systems
D. Hallifax et al.
CURRENT DRUG METABOLISM (2009)
Determination of mRNA Expression of Human UDP-Glucuronosyltransferases and Application for Localization in Various Human Tissues by Real-Time Reverse Transcriptase-Polymerase Chain Reaction
Shuji Ohno et al.
DRUG METABOLISM AND DISPOSITION (2009)
Prediction of Drug Clearance by Glucuronidation from in Vitro Data: Use of Combined Cytochrome P450 and UDP-Glucuronosyltransferase Cofactors in Alamethicin-Activated Human Liver Microsomes
Peter J. Kilford et al.
DRUG METABOLISM AND DISPOSITION (2009)
Dopamine Is a Low-Affinity and High-Specificity Substrate for the Human UDP-Glucuronosyltransferase 1A10
Katriina Itaaho et al.
DRUG METABOLISM AND DISPOSITION (2009)
Deferiprone Glucuronidation by Human Tissues and Recombinant UDP Glucuronosyltransferase 1A6: An in Vitro Investigation of Genetic and Splice Variants
Marie-Odile Benoit-Biancamano et al.
DRUG METABOLISM AND DISPOSITION (2009)
Characterization of the Binding of Drugs to Human Intestinal Fatty Acid Binding Protein (IFABP): Potential Role of IFABP as an Alternative to Albumin for in Vitro-in Vivo Extrapolation of Drug Kinetic Parameters
Andrew Rowland et al.
DRUG METABOLISM AND DISPOSITION (2009)
Relative Importance of Intestinal and Hepatic Glucuronidation-Impact on the Prediction of Drug Clearance
Helen E. Cubitt et al.
PHARMACEUTICAL RESEARCH (2009)
The human UDP-glucuronosyltransferase UGT1A3 is highly selective towards N2 in the tetrazole ring of losartan, candesartan, and zolarsartan
Anna Alonen et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Contribution of the N-glucuronidation pathway to the overall in vitro metabolic clearance of midazolam in humans
Sylvie Klieber et al.
DRUG METABOLISM AND DISPOSITION (2008)
The Albumin Effect and drug glucuronidation: Bovine serum albumin and fatty acid-free human serum albumin enhance the glucuronidation of UDP-glucuronosyltransferase (UGT) 1A9 substrates but not UGT1A1 and UGT1A6 activities
Andrew Rowland et al.
DRUG METABOLISM AND DISPOSITION (2008)
The Configuration of the 17-Hydroxy Group Variably Influences the Glucuronidation of β-Estradiol and Epiestradiol by Human UDP-Glucuronosyltransferases
Katriina Itaaho et al.
DRUG METABOLISM AND DISPOSITION (2008)
Regio- and stereospecific N-glucuronidation of medetomidine:: The differences between UDP glucuronosyltransferase (UGT) 1A4 and UGT2B10 account for the complex kinetics of human liver microsomes
Sanna Kaivosaari et al.
DRUG METABOLISM AND DISPOSITION (2008)
The albumin effect and in vitro-in vivo extrapolation: Sequestration of long-chain unsaturated fatty acids enhances phenytoin hydroxylation by human liver microsomal and recombinant cytochrome P4502C9
Andrew Rowland et al.
DRUG METABOLISM AND DISPOSITION (2008)
Effect of the β-glucuronidase inhibitor saccharolactone on glucuronidation by human tissue microsomes and recombinant UDP-glucuronosyltransferases
Lauren Oleson et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2008)
Kinetic modeling of the interactions between 4-methylumbelliferone, 1-naphthol, and zidovudine glucuronidation by UDP-glucuronosyltransferase 2B7 (UGT2B7) provides evidence for multiple substrate binding and effector sites
Verawan Uchaipichat et al.
MOLECULAR PHARMACOLOGY (2008)
Contribution of UDP-glucuronosyltransferase 1A1 and 1A8 to morphine-6-glucuronidation and its kinetic properties
Shuji Ohno et al.
DRUG METABOLISM AND DISPOSITION (2008)
Characterization of 1′-hydroxymidazolam glucuronidation in human liver microsomes
Bing Zhu et al.
DRUG METABOLISM AND DISPOSITION (2008)
Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates
Wandee Udomuksorn et al.
PHARMACOGENETICS AND GENOMICS (2007)
The UDP-glucuronosyltransferase 2B7 isozyme is responsible for gemfibrozil glucuronidation in the human liver
Yuji Mano et al.
DRUG METABOLISM AND DISPOSITION (2007)
Critical roles of residues 36 and 40 in the phenol and tertiary amine aglycone substrate selectivities of UDP-glucuronosyltransferases 1A3 and 1A4
Takahiro Kubota et al.
MOLECULAR PHARMACOLOGY (2007)
Glucuronidation of nicotine and cotinine by UGT2B10:: Loss of function by the UGT2B10 codon 67 (Asp>Tyr) polymorphism
Gang Chen et al.
CANCER RESEARCH (2007)
Nicotine glucuronidation and the human UDP-glucuronosyltransferase UGT2B10
Sanna Kaivosaari et al.
MOLECULAR PHARMACOLOGY (2007)
Saturable uptake of lipophilic amine drugs into isolated hepatocytes: Mechanisms and consequences for quantitative clearance prediction
David Hallifax et al.
DRUG METABOLISM AND DISPOSITION (2007)
Predominant contribution of UDP-glucuronosyltransferase 2B7 in the glucuronidation of racemic flurbiprofen in the human liver
Yuji Mano et al.
DRUG METABOLISM AND DISPOSITION (2007)
Glucuronidation of fenamates: Kinetic studies using human kidney cortical microsomes and recombinant UDP-glucuronosyltransferase (UGT) 1A9 and ZB7
Paraskevi Gaganis et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Amino terminal domains of human UDP-glucuronosyltransferases (UGT) 2B7 and 2B15 associated with substrate selectivity and autoactivation
Benjamin C. Lewis et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Binding of inhibitory fatty acids is responsible for the enhancement of UDP-glucuronosyltransferase 2B7 activity by albumin: Implications for in vitro-in vivo extrapolation
Andrew Rowland et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
UDP-glucuronosyltransferase 1A1 is the principal enzyme responsible for etoposide glucuronidation in human liver and intestinal microsomes: Structural characterization of phenolic and alcoholic glucuronides of etoposide and estimation of enzyme kinetics
Zhiming Wen et al.
DRUG METABOLISM AND DISPOSITION (2007)
The glucuronidation of Δ4-3-keto C19- and C21-hydroxysteroids by human liver microsomal and recombinant UDP-glucuronosyltransferases (UGTs):: 6α- and 21-hydroxyprogesterone are selective substrates for UGT2B7
K. Bowalgaha et al.
DRUG METABOLISM AND DISPOSITION (2007)
Glucuronidation of anti-HIV drug candidate bevirimat: Identification of human UDP-glucuronosyltransferases and species differences
Zhiming Wen et al.
DRUG METABOLISM AND DISPOSITION (2007)
Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data:: Reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver
Zoe E. Barter et al.
CURRENT DRUG METABOLISM (2007)
Glucuronidation of antiallergic drug, tranilast: Identification of human UDP-glucuronosyltransferase isoforms and effect of its phase I metabolite
Miki Katoh et al.
DRUG METABOLISM AND DISPOSITION (2007)
Sulfinpyrazone C-glucuronidation is catalyzed selectively by human UDP-glucuronosyltransferase 1A9
Oranun Kerdpin et al.
DRUG METABOLISM AND DISPOSITION (2006)
The importance of local chemical structure for chemical metabolism by human uridine 5′-diphosphate -: Glucuronosyltransferase
Michael J. Sorich et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2006)
Identification of human UDP-glucuronosyltransferase isoform(s) responsible for the C-glucuronidation of phenylbutazone
Takahito Nishiyama et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2006)
In vitro-in vivo correlation for drugs and other compounds eliminated by glucuronidation in humans: Pitfalls and promises
JO Miners et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Relationship between hyperbilirubinaemia and UDP-glucuronosyltransferase 1A1 (UGT1A1) polymorphism in adult HIV-infected Thai patients treated with indinavir
Mark A. Boyd et al.
PHARMACOGENETICS AND GENOMICS (2006)
Quantitative prediction of in vivo inhibitory interactions involving glucuronidated drugs from in vitro data:: the effect of fluconazole on zidovudine glucuronidation
V Uchaipichat et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Altered AZT (3′-azido-3′-deoxythymidine) glucuronidation kinetics in liver microsomes as an explanation for underprediction of in vivo clearance:: Comparison to hepatocytes and effect of incubation environment
JJ Engtrakul et al.
DRUG METABOLISM AND DISPOSITION (2005)
S-Naproxen and desmethylnaproxen glucuronidation by human liver microsomes and recombinant human UDP-glucuronosyltransferases (UGT): role of UGT2B7 in the elimination of naproxen
K Bowalgaha et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily
PI Mackenzie et al.
PHARMACOGENETICS AND GENOMICS (2005)
A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes
RJ Riley et al.
DRUG METABOLISM AND DISPOSITION (2005)
In vitro metabolism study of buprenorphine: Evidence for new metabolic pathways
N Picard et al.
DRUG METABOLISM AND DISPOSITION (2005)
UDP-glucuronosyltransferases and clinical drug-drug interactions
TKL Kiang et al.
PHARMACOLOGY & THERAPEUTICS (2005)
Regioselective glucuronidation of denopamine: Marked species differences and identification of human UDP-glucuronosyltransferase isoform
H Kaji et al.
DRUG METABOLISM AND DISPOSITION (2005)
Metabolism of 26,26,26,27,27,27-F-6-1 alpha,23S,25-trihydroxyvitamin D-3 by human UDP-glucuronosyltransferase 1A3*
N Kasai et al.
DRUG METABOLISM AND DISPOSITION (2005)
Prediction of human drug clearance from in vitro and preclinical data using physiologically based and empirical approaches
K Ito et al.
PHARMACEUTICAL RESEARCH (2005)
Human UDP-glucuronosyltransferases: Isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid
V Uchaipichat et al.
DRUG METABOLISM AND DISPOSITION (2004)
Database analyses for the prediction of in vivo drug-drug interactions from in vitro data
K Ito et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Predicting drug clearance from recombinantly expressed CYPs: intersystem extrapolation factors
NJ Proctor et al.
XENOBIOTICA (2004)
Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of posaconazole (Noxafil)
A Ghosal et al.
DRUG METABOLISM AND DISPOSITION (2004)
Substrate depletion approach for determining in vitro metabolic clearance: Time dependencies in hepatocyte and microsomal incubations
HM Jones et al.
DRUG METABOLISM AND DISPOSITION (2004)
The main role of UGT1A9 in the hepatic metabolism of mycophenolic acid and the effects of naturally occurring variants
O Bernard et al.
DRUG METABOLISM AND DISPOSITION (2004)
UDP-glucuronosyltransferase (UGT) 2B15 pharmacogenetics: UGT2B15 D85Y genotype and gender are major determinants of oxazepam glucuronidation by human liver
MH Court et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
An assessment of udp-glucuronosyltransferase induction using primary human hepatocytes
MG Soars et al.
DRUG METABOLISM AND DISPOSITION (2004)
Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyltransferases (UGT): kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7
P Tsoutsikos et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Specificity and regioselectivity of the conjugation of estradiol, estrone, and their catecholestrogen and methoxyestrogen metabolites by human uridine diphospho-glucuronosyltransferases expressed in endometrium
J Lépine et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Isoform selectivity and kinetics of morphine 3-and 6-glucuronidation by human UDP-glucuronosyltransferases: Evidence for atypical glucuronidation kinetics by UGT2B7
AN Stone et al.
DRUG METABOLISM AND DISPOSITION (2003)
Evaluation of 3′-azido-3′-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes:: Specificity and influence of the UGT2B7*2 polymorphism
MH Court et al.
DRUG METABOLISM AND DISPOSITION (2003)
The effect of incubation conditions on the enzyme kinetics of UDP-glucuronosyltransferases
MG Soars et al.
DRUG METABOLISM AND DISPOSITION (2003)
Pharmacogenomics of human UDP-glucuronosyltransferase enzymes
C Guillemette
PHARMACOGENOMICS JOURNAL (2003)
Validation of serotonin (5-hydroxtryptamine) as an in vitro substrate probe for human UDP-glucuronosyltransferase (UGT) 1A6
S Krishnaswamy et al.
DRUG METABOLISM AND DISPOSITION (2003)
Genetic polymorphisms of UDP-glucuronosyltransferases and their functional significance
JO Miners et al.
TOXICOLOGY (2002)
Differential modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1) catalyzed estradiol-3-glucuronidation by the addition of UGT1A1 substrates and other compounds to human liver microsomes
JA Williams et al.
DRUG METABOLISM AND DISPOSITION (2002)
In vitro-in vivo correlations for drugs eliminated by glucuronidation:: Investigations with the model substrate zidovudine
S Boase et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Stereoselective conjugation of oxazepam by human UDP-glucuronosyltransferases (UGTS):: S-oxazepam is glucuronidated by UGT2B15, while R-oxazepam is glucuronidated by UGT2B7 and UGT1A9
MH Court et al.
DRUG METABOLISM AND DISPOSITION (2002)
Glucuronidation of olanzapine by cDNA-expressed human UDP-glucuronosyltransferases and human liver microsomes
K Linnet
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2002)
Imipramine N-glucuronidation in human liver microsomes:: Biphasic kinetics and characterization of UDP-glucuronosyltransferase isoforms
M Nakajima et al.
DRUG METABOLISM AND DISPOSITION (2002)
In vitro analysis of human drug glucuronidation and prediction of in vivo metabolic clearance
MG Soars et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Nonspecific binding of drugs to human liver microsomes
JA McLure et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2000)
分享论文
